Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery.

Yadavalli T, Ames J, Agelidis A, Suryawanshi R, Jaishankar D, Hopkins J, Thakkar N, Koujah L, Shukla D.

Sci Adv. 2019 Aug 14;5(8):eaax0780. doi: 10.1126/sciadv.aax0780. eCollection 2019 Aug.

2.

Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development.

Kaltenbach DD, Jaishankar D, Hao M, Beer JC, Volin MV, Desai UR, Tiwari V.

Front Pharmacol. 2018 Nov 22;9:1315. doi: 10.3389/fphar.2018.01315. eCollection 2018. Review.

3.

Swept-source optical coherence tomography study of choroidal morphology in Stargardt disease.

Ratra D, Jaishankar D, Sachidanandam R, Yusufali H, Ratra V.

Oman J Ophthalmol. 2018 May-Aug;11(2):150-157. doi: 10.4103/ojo.OJO_21_2017.

4.

Herpesvirus-encoded microRNAs detected in human gingiva alter host cell transcriptome and regulate viral infection.

Naqvi AR, Seal A, Shango J, Brambila MF, Martinez G, Chapa G, Hasan S, Yadavalli T, Jaishankar D, Shukla D, Nares S.

Biochim Biophys Acta Gene Regul Mech. 2018 May;1861(5):497-508. doi: 10.1016/j.bbagrm.2018.03.001. Epub 2018 Mar 15.

5.

An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye.

Jaishankar D, Yakoub AM, Yadavalli T, Agelidis A, Thakkar N, Hadigal S, Ames J, Shukla D.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaan5861. doi: 10.1126/scitranslmed.aan5861.

PMID:
29444978
6.

Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection.

Yadavalli T, Agelidis A, Jaishankar D, Mangano K, Thakkar N, Penmetcha K, Shukla D.

Mol Ther Nucleic Acids. 2017 Dec 15;9:365-378. doi: 10.1016/j.omtn.2017.10.009. Epub 2017 Oct 17.

7.

CHOROIDAL STRUCTURAL CHANGES AND VASCULARITY INDEX IN STARGARDT DISEASE ON SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY.

Ratra D, Tan R, Jaishankar D, Khandelwal N, Gupta A, Chhablani J, Agrawal R.

Retina. 2018 Dec;38(12):2395-2400. doi: 10.1097/IAE.0000000000001879.

PMID:
29016459
8.

CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

Wagner JA, Rosario M, Romee R, Berrien-Elliott MM, Schneider SE, Leong JW, Sullivan RP, Jewell BA, Becker-Hapak M, Schappe T, Abdel-Latif S, Ireland AR, Jaishankar D, King JA, Vij R, Clement D, Goodridge J, Malmberg KJ, Wong HC, Fehniger TA.

J Clin Invest. 2017 Nov 1;127(11):4042-4058. doi: 10.1172/JCI90387. Epub 2017 Oct 3.

9.

Emerging Roles of Heparanase in Viral Pathogenesis.

Thakkar N, Yadavalli T, Jaishankar D, Shukla D.

Pathogens. 2017 Sep 18;6(3). pii: E43. doi: 10.3390/pathogens6030043. Review.

10.

Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Agelidis AM, Hadigal SR, Jaishankar D, Shukla D.

Cell Rep. 2017 Jul 11;20(2):439-450. doi: 10.1016/j.celrep.2017.06.041.

11.

Genital Herpes: Insights into Sexually Transmitted Infectious Disease.

Jaishankar D, Shukla D.

Microb Cell. 2016 Jun 27;3(9):438-450. doi: 10.15698/mic2016.09.528. Review.

12.

Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas.

Duggal N, Jaishankar D, Yadavalli T, Hadigal S, Mishra YK, Adelung R, Shukla D.

Mol Vis. 2017 Feb 26;23:26-38. eCollection 2017.

13.

Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells.

Thakkar N, Jaishankar D, Agelidis A, Yadavalli T, Mangano K, Patel S, Tekin SZ, Shukla D.

Sci Rep. 2017 Feb 15;7:42559. doi: 10.1038/srep42559.

14.

Liposome-Mediated Herpes Simplex Virus Uptake Is Glycoprotein-D Receptor-Independent but Requires Heparan Sulfate.

Burnham LA, Jaishankar D, Thompson JM, Jones KS, Shukla D, Tiwari V.

Front Microbiol. 2016 Jun 22;7:973. doi: 10.3389/fmicb.2016.00973. eCollection 2016.

15.

Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.

Jaishankar D, Buhrman JS, Valyi-Nagy T, Gemeinhart RA, Shukla D.

Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):169-80. doi: 10.1167/iovs.15-18365.

16.

Characterization of a proteolytically stable D-peptide that suppresses herpes simplex virus 1 infection: implications for the development of entry-based antiviral therapy.

Jaishankar D, Yakoub AM, Bogdanov A, Valyi-Nagy T, Shukla D.

J Virol. 2015 Feb;89(3):1932-8. doi: 10.1128/JVI.02979-14. Epub 2014 Nov 26.

Supplemental Content

Loading ...
Support Center